TheEdgeResearch
Home / Stocks / NEOG

Neogen Corporation (NEOG)

NASDAQ Healthcare Medical - Devices
$10.55 ▼ -2.76%
Market Cap
$2.30B
Sector
Healthcare
Industry
Medical - Devices
Beta
1.86
52-Wk Range
5.6-14.26
CEO
Mikhael Nassif
Country
US
Currency
USD

Neogen Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Lansing, MI, US. The stock last traded at $10.55, down 2.76% on the session, giving a market capitalisation of $2.30B. On trailing twelve-month figures it carries a trailing P/E of -41.67, a net margin of -6.3%. Its beta of 1.86 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-41.67
Price / Sales
2.61
Price / Book
1.10
EV / EBITDA
27.64
Gross margin
47.4%
Operating margin
-0.8%
Net margin
-6.3%
Return on equity
—
Debt / equity
0.37
Current ratio
3.90
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
2,636
IPO date
1989-08-23
Headquarters
Lansing, MI, US
About Neogen Corporation

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Comparable companies

Neogen Corporation is most often compared with the following Healthcare names:

BCPCELANIDXXMRKPAHCZTS
More research on NEOG
NEOG technical analysis NEOG TheEdge Score Compare against peers
Open full interactive analysis & DCF →